Hospira, Inc.

LAKE FOREST, Ill., May 1, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the first quarter ended March 31, 2013. Adjusted* net sales for the quarter were $988 million and adjusted* diluted earnings ... read more

LAKE FOREST, Ill., May 1, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today unveiled details of its global device strategy. The initiative establishes a streamlined and modernized device portfolio to address customer needs and position the company for future innovation ... read more

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced an important milestone, commemorating five years ... read more

LAKE FOREST, Ill., April 17, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at two upcoming conferences: -- Bank of America Merrill Lynch 2013 Health Care ConferenceMay 15, 2013 ... read more

LAKE FOREST, Ill., April 15, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, announced that Matthew R. (Matt) Stober has been named senior vice president, Operations, effective today. In addition to expanding his current U.S. responsibilities to assume ... read more

LAKE FOREST, Ill., April 2, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its first-quarter 2013 results on Wednesday, May 1, 2013 at 8 a.m. Central time.  The company will release its first-quarter results ... read more

LAKE FOREST, Ill., March 18, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for Hospira's alpha-2 agonist Precedex((TM)) (dexmedetomidine HCl) injection. Based on this decision by the ... read more

LAKE FOREST, Ill., March 1, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that Royce R. Bedward has been appointed corporate vice president, general counsel and secretary, effective immediately. In his new role, Mr. Bedward will ... read more

LAKE FOREST, Ill., Feb. 13, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the fourth quarter and full year ended Dec. 31, 2012. For the fourth quarter of 2012, net sales were $1.1 ... read more

LAKE FOREST, Ill., Feb. 5, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at two upcoming conferences: -- Raymond James 34(th )Institutional Investors ConferenceMarch 5, 2013 ... read more

LAKE FOREST, Ill., Jan. 23, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that its TheraDoc(TM) Infection Control Assistant(TM) has been ranked as the top product in the Infection Control & Monitoring software category in the ... read more

LAKE FOREST, Ill., and PETACH TIKVA, Israel, Jan. 22, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and Q Core Medical, Ltd., an innovation leader in infusion delivery systems, today announced that the companies have entered into ... read more

LAKE FOREST, Ill., Dec. 20, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its fourth-quarter and full-year 2012 results and projections for 2013 on Wednesday, Feb. 13, 2013, at 8 a.m. ... read more

LAKE FOREST, Ill., Dec. 10, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the J.P. Morgan 31st Annual Healthcare Conference on Tuesday, Jan. 8, 2013, in San Francisco. The ... read more